How to Buy Acutaas Chemicals Ltd Shares?
You can easily buy the stocks/shares of Acutaas Chemicals Ltd (ACUTAAS) on Tickertape or through broker platform by opening a Demat & Trading account onlineWhat is the Share Price of Acutaas Chemicals Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of ACUTAAS as on 15th May 2025 is ₹1155.88What is the return on Acutaas Chemicals Ltd share?
The past returns of Acutaas Chemicals Ltd (ACUTAAS) share are- Past 1 week: N/A
- Past 1 month: -68.38
- Past 3 months: 1.23
- Past 6 months: 4.07
- Past 1 year: 66.85
- Past 3 years: 148.85
- Past 5 years: 136.30
What is the Dividend yield % on Acutaas Chemicals Ltd share?
The current dividend yield of Acutaas Chemicals Ltd (ACUTAAS) is 0.12What is the Market Cap of Acutaas Chemicals Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Acutaas Chemicals Ltd (ACUTAAS) is ₹9032.11Cr as of 15th May 2025What is the 52 Week High and Low of Acutaas Chemicals Ltd?
The 52-week high and low of Acutaas Chemicals Ltd (ACUTAAS) is ₹1322 and ₹607.50.What is the PE and PB ratio of Acutaas Chemicals Ltd?
The P/E (price-to-earnings) and P/B (price-to-book) ratios of Acutaas Chemicals Ltd are 56.91 and 13.23 respectively.Which sector does Acutaas Chemicals Ltd belong to?
Acutaas Chemicals Ltd (ACUTAAS) belongs to the Health Care sector & Biotechnology sub-sector.What are the peers or stocks similar to Acutaas Chemicals Ltd?
The peers or stocks similar to Acutaas Chemicals Ltd are: and many others.Can't decide whether or not to buy Acutaas Chemicals Ltd?
Worry no more! Login to Tickertape and check out Acutaas Chemicals Ltd (ACUTAAS) scorecard & all the relevant insights today5. Test Stocks FAQ What is the 52 Week High and Low of Acutaas Chemicals Ltd?
The 52-week high and low of Acutaas Chemicals Ltd (ACUTAAS) is ₹1322 and ₹607.50.1. Test Stocks FAQ for Acutaas Chemicals Ltd Shares?
You can easily buy the stocks/shares of Acutaas Chemicals Ltd (ACUTAAS) on Tickertape or through broker platform by opening a Google & Trading account online3. Test Stocks FAQ What is the Share Price of Acutaas Chemicals Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of ACUTAAS as on 15th May 2025 is ₹1155.88
Acutaas Chemicals Ltd
ACUTAAS Share Price
1,155.880.02% (+0.18)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
ACUTAAS Performance & Key Metrics
ACUTAAS Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 56.91 | 13.23 | 0.12% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.21 | 6.66 | 0.83% |
ACUTAAS Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
ACUTAAS Company Profile
Acutaas Chemicals Limited specializes in manufacturing pharmaceutical intermediates and specialty chemicals for various industries, including pharmaceuticals and agrochemicals, with over 520 products developed across multiple therapeutic areas.
BIOCON
PE Ratio
41.96
41.96
1Y Return
5.10%
5.10%
Buy Reco %
63.64
63.64
ONESOURCE
PE Ratio
-1,288.76
-1,288.76
1Y Return
18.44%
18.44%
Buy Reco %
—
—
SAILIFE
PE Ratio
94.24
94.24
1Y Return
11.24%
11.24%
Buy Reco %
—
—
PANACEABIO
PE Ratio
-329.60
-329.60
1Y Return
237.90%
237.90%
Buy Reco %
—
—
HESTERBIO
PE Ratio
57.43
57.43
1Y Return
1.69%
1.69%
Buy Reco %
0.00
0.00
ACUTAAS Sentiment Analysis
ACUTAAS Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
ACUTAAS Stock Summary · January 2025
Company is navigating a complex landscape characterized by declining market share in deposits, challenges in meeting Priority Sector Lending (PSL) obligations, and fluctuations in current account flows. Despite these hurdles, the bank is focusing on enhancing customer engagement and service delivery to drive deposit growth, with recent monthly inflows showing a positive trend. The management emphasizes a strategic approach to maintaining profitability over aggressive expansion, particularly in light of competitive pressures and a tight liquidity environment. Efforts to improve operational efficiencies through digitization and a commitment to stable cost management are underway, alongside a proactive strategy to reduce borrowings and strengthen the balance sheet. Overall, while facing short-term challenges, the bank remains optimistic about future performance and is committed to achieving sustainable growth through strategic investments and improved customer outreach.
ACUTAAS Stock Growth Drivers
ACUTAAS Stock Growth Drivers
1Focus on Sustainable Growth
Company is prioritizing profitable growth over mere expansion, emphasizing a strategy that encourages ground-level teams
ACUTAAS Stock Challenges
ACUTAAS Stock Challenges
3Deposit Growth Shortfalls
The company has experienced deposit growth that has not met expectations, attributed to seasonal trends
Loan Growth Concerns
There is uncertainty regarding the company's loan deposit ratio (LDR) and its implications for loan
ACUTAAS Forecast
What are forecasts?
What are forecasts?
Forecasting uses historical data as inputs to make informed predictive estimates determining the direction of future trends. Price, revenue & earnings forecasts represent where the stock level, business prospects and profits are potentially expected to be at the end of the forecast period
ACUTAAS Forecasts
Price
Revenue
Earnings
ACUTAAS Share Price Forecast
ACUTAAS Share Price Forecast
2025
Current
₹1,104.70
Baseline
Forecast for Jun 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹1,104.70
Baseline
Forecast for Jun 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
ACUTAAS Company Revenue Forecast
ACUTAAS Company Revenue Forecast
2025
Current
₹1.02
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2025
Current
₹1.02
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
ACUTAAS Stock EPS (Earnings Per Share) Forecast
ACUTAAS Stock EPS (Earnings Per Share) Forecast
2025
Current
₹9.91
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹9.91
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
ACUTAAS
ACUTAAS
Income
Balance Sheet
Cash Flow
Annual Normal View
ACUTAAS Income Statement
ACUTAAS Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 160.47 | 191.18 | 238.89 | 242.48 | 341.99 | 522.90 | 621.05 | 724.96 | 1,023.80 | 1,023.80 | ||||||||||
Raw Materials | 94.75 | 114.72 | 151.95 | 137.96 | 174.87 | 282.33 | 345.85 | 440.17 | 774.80 | 774.80 | ||||||||||
| Power & Fuel Cost | 1.00 | 1.27 | 4.14 | 4.54 | 5.26 | 21.40 | 22.28 | 25.82 | ||||||||||||
| Employee Cost | 7.38 | 9.89 | 8.54 | 12.95 | 21.01 | 41.37 | 48.84 | 63.11 | ||||||||||||
| Selling & Administrative Expenses | 17.60 | 12.56 | 14.77 | 15.38 | 12.13 | 27.34 | 36.69 | 33.12 | ||||||||||||
| Operating & Other expenses | 16.40 | 19.26 | 17.03 | 27.79 | 47.18 | 42.51 | 40.46 | 58.85 | ||||||||||||
EBITDA | 23.34 | 33.48 | 42.46 | 43.86 | 81.54 | 107.95 | 126.93 | 103.89 | 249.00 | 249.00 | ||||||||||
| Depreciation/Amortization | 1.37 | 1.91 | 2.60 | 3.52 | 4.19 | 10.08 | 12.34 | 16.06 | 26.62 | 26.63 | ||||||||||
| PBIT | 21.97 | 31.57 | 39.86 | 40.34 | 77.35 | 97.87 | 114.59 | 87.83 | 222.38 | 222.37 | ||||||||||
| Interest & Other Items | 3.30 | 3.23 | 4.75 | 5.59 | 5.62 | 6.41 | 2.41 | 5.94 | 6.22 | 6.22 | ||||||||||
| PBT | 18.67 | 28.34 | 35.11 | 34.75 | 71.73 | 91.46 | 112.18 | 81.89 | 216.16 | 216.15 | ||||||||||
| Taxes & Other Items | 6.63 | 9.86 | 11.81 | 7.29 | 17.72 | 19.50 | 28.88 | 39.14 | 57.45 | 57.44 | ||||||||||
| Net Income | 12.04 | 18.48 | 23.30 | 27.46 | 54.01 | 71.96 | 83.30 | 42.75 | 158.71 | 158.71 | ||||||||||
| EPS | 1.91 | 2.93 | 3.70 | 4.36 | 8.57 | 10.59 | 11.43 | 5.83 | 9.91 | 21.52 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.14 | 0.13 | 0.26 | 0.15 | 0.07 |
ACUTAAS Company Updates
FY 2025FY 2025
Investor Presentation
May 2PDF
Jan 28PDF
ACUTAAS Stock Peers
What are peers and why compare against them?
What are peers and why compare against them?
A stock's peers are companies which have similar business interests, operations and belong to the same industry sector. Comparing various metrics against peers can give valuable insights on whether the company's stock is over/under-valued and the company's growth outlook vs the industry as a whole
ACUTAAS Past Performance & Peer Comparison
ACUTAAS Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareBiotechnology
Compare valuation-basic on Screener
Health CareBiotechnology
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Acutaas Chemicals Ltd | 56.91 | 13.23 | 0.12% |
| Biocon Ltd | 41.96 | 1.68 | 0.35% |
| Onesource Specialty Pharma Ltd | -1,288.76 | 58.49 | — |
| Sai Life Sciences Ltd | 94.24 | 16.44 | — |
ACUTAAS Stock Price Comparison
Compare ACUTAAS with any stock or ETFCompare ACUTAAS with any stock or ETF
ACUTAAS
ACUTAAS Holdings
ACUTAAS Shareholdings
What are shareholdings?
What are shareholdings?
Apart from retail investors, a company’s shares are held by promoters, foreign & domestic institutions (large investors) and mutual funds. Promoters are the ship captains and control the company’s direction. Along with institutional and mutual fund holdings, a change in their holdings can indicate performance outlook for the stock
ACUTAAS Promoter Holdings Trend
ACUTAAS Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
ACUTAAS Institutional Holdings Trend
ACUTAAS Institutional Holdings Trend
Increased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has increased by 1.07%
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
ACUTAAS Shareholding Pattern
ACUTAAS Shareholding Pattern
ACUTAAS Shareholding History
ACUTAAS Shareholding History
Foreign Institutions
Mutual Funds Invested in ACUTAAS
Mutual Funds Invested in ACUTAAS
No mutual funds holding trends are available
Top 5 Mutual Funds holding Acutaas Chemicals Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 3.3415% | Percentage of the fund’s portfolio invested in the stock 0.96% | Change in the portfolio weight of the stock over the last 3 months 0.96% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 42/81 (+38) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 2.2421% | Percentage of the fund’s portfolio invested in the stock 2.04% | Change in the portfolio weight of the stock over the last 3 months 2.04% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 21/61 (+22) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.3807% | Percentage of the fund’s portfolio invested in the stock 3.38% | Change in the portfolio weight of the stock over the last 3 months 3.38% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 10/32 (+11) |
Compare 3-month MF holding change on Screener
smallcases containing ACUTAAS stock
smallcases containing ACUTAAS stock
Looks like this stock is not in any smallcase yet.
ACUTAAS Events
ACUTAAS Events
ACUTAAS Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
What are dividends?
What are dividends?
Dividends are a portion of earnings that a company distributes to all its shareholders every year. Dividend return is one of the most important things to be considered while investing for long term. It’s the additional return on top of what investors earn through price appreciation
ACUTAAS Dividend Trend
No dividend trend available
ACUTAAS Upcoming Dividends
ACUTAAS Upcoming Dividends
No upcoming dividends are available
ACUTAAS Past Dividends
ACUTAAS Past Dividends
Cash Dividend
Ex DateEx DateSep 13, 2024
Final
Final | Div/Share: ₹3.00
Dividend/Share
₹3.00
Ex DateEx Date
Sep 13, 2024
Cash Dividend
Ex DateEx DateSep 17, 2023
Final
Final | Div/Share: ₹3.00
Dividend/Share
₹3.00
Ex DateEx Date
Sep 17, 2023
Cash Dividend
Ex DateEx DateJul 29, 2022
Final
Final | Div/Share: ₹3.00
Dividend/Share
₹3.00
Ex DateEx Date
Jul 29, 2022
ACUTAAS Stock News & Opinions
ACUTAAS Stock News & Opinions
Articles & Videos
Spotlight
Ami Organics jumps after Q4 PAT soars to Rs 627 cr
Revenue from operations jumped 37.13% year on year to Rs 308.48 crore during the quarter ended 31st March 2025. Profit before tax (PBT) soared 122.66% to Rs 82.83 crore in Q4 FY25 as compared with Rs 37.20 crore in Q4 FY24. EBITDA stood at Rs 85 crore, registering the growth of 96.8% as compared with Rs 432 crore in Q4 FY24. EBITDA margin was at 27.5% in Q4 FY25 as against 19.2% in Q4 FY24. In Q4 FY25, export stood at 74% and domestic business was at 26%. Naresh Patel, executive chairman & managing director, Ami Organics, said, 'I am delighted to share that FY25 was a transformative year for Ami Organics, as we proudly surpassed Rs 1,000 crore in revenue'a remarkable milestone. This achievement reflects the unwavering dedication of our employees and the invaluable support of our stakeholders, including customers, suppliers, shareholders and all other stakeholders. We extend our heartfelt gratitude for their contributions. Looking ahead to FY26, we anticipate robust growth across all business segments, driving our confidence in achieving 25% revenue growth.' Meanwhile, the company's board recommended of final dividend of Rs 1.5 per equity share for FY25 Ami Organics headquartered at Surat, is a research and development (R&D) driven manufacturer of speciality chemicals focused towards the development and manufacturing of advanced pharmaceutical intermediates for regulated and generic active pharmaceutical ingredients (APIs) and chemicals for New Chemical Entities (NCE), and other specialty chemicals.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Ami Organics consolidated net profit rises 148.43% in the March 2025 quarter
Net profit of Ami Organics rose 148.43% to Rs 62.48 crore in the quarter ended March 2025 as against Rs 25.15 crore during the previous quarter ended March 2024. Sales rose 37.13% to Rs 308.48 crore in the quarter ended March 2025 as against Rs 224.96 crore during the previous quarter ended March 2024. For the full year,net profit rose 271.08% to Rs 158.71 crore in the year ended March 2025 as against Rs 42.77 crore during the previous year ended March 2024. Sales rose 40.34% to Rs 1006.88 crore in the year ended March 2025 as against Rs 717.47 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales308.48224.96 37 1006.88717.47 40 OPM %27.5419.19 -23.0517.91 - PBDT90.1342.43 112 242.78130.04 87 PBT82.8337.53 121 216.16113.98 90 NP62.4825.15 148 158.7142.77 271 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Board of AMI Organics recommends final dividend
AMI Organics announced that the Board of Directors of the Company at its meeting held on 2 May 2025, inter alia, have recommended the final dividend of Rs 1.5 per equity Share (i.e. 30%) , subject to the approval of the shareholders.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
AMI Organics to hold board meeting
AMI Organics will hold a meeting of the Board of Directors of the Company on 2 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Ami Organics' Unit II receives Japan PMDA nod for GMP compliance
Ami Organics' manufacturing facility, Unit II situated at Ankleshwar, which is involved in manufacturing of various intermediates for Active Pharmaceuticals Ingredients, has received Good Manufacturing Practices (GMP) by Pharmaceutical and Medical Devices Agency, Japan (PMDA). Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
AMI Organics to hold EGM
AMI Organics announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 10 May 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Board of Ami Organics approves change in company name to Acutaas Chemicals
The Board of Ami Organics at its meeting held on 16 April 2025 has approved the change in the name of the Company from 'Ami Organics' to 'Acutaas Chemicals', and the consequential alteration the Memorandum of Association and Articles of Association to give effect to the same. Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Ami Organics commissions 10.8 MW DC solar power plant
Ami Organics announced the full commissioning of its 10.8 MW DC solar power plant. The solar facility, located at Pratapnagar, Nandod, Narmada District, Gujarat, India, comprises two captive solar plants, each with a capacity of 5.4 MW. Speaking on this significant achievement, Naresh Patel, Chairman and Managing Director of Ami Organics Limited, stated: 'The successful commissioning of our 10.8MW solar power plant marks a crucial step in our journey towards a greener and more sustainable future. This project not only strengthens our commitment to environmental responsibility but also enhances our operational efficiency and cost-effectiveness. With our continued investment in renewable energy, we aim to make substantial progress in reducing our dependence on conventional power sources and moving towards a cleaner, and more sustainable energy portfolio.'Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
AMI Organics announces board meeting date
AMI Organics will hold a meeting of the Board of Directors of the Company on 21 February 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Board of Ami Organics to consider stock split
The Board of Ami Organics will meet on 21 February 2025 to consider the proposal for alteration in the share capital of the Company by way of sub-division / split of the existing equity shares of the face value Rs 10/- each. Powered by Capital Market - Live
3 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 24.86%, vs industry avg of 19.23%
Over the last 5 years, market share increased from 3.02% to 3.78%
Over the last 5 years, net income has grown at a yearly rate of 12.91%, vs industry avg of 2.33%